• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Drug Injection Devices to 2020 - Product Image

Drug Injection Devices to 2020

  • Published: June 2014
  • Region: Global
  • Greystone Associates
Devices, Products, Markets, Strategies and Forecasts

As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug designers and marketers. The injectable device sector today consists of a half-dozen established device classes and two emerging classes. For the remainder of the decade, pipeline drugs and shifting demographics will drive sector growth as an aging population of baby boomers (23% of US population) provides stimulus for industry demand. Currently, the over 65 segment accounts for approximately 13% of the US population, with an estimated 40% of total healthcare expenditures, but by 2020, this segment is expected to grow to 17% of the population. This aging of the population will predominately benefit products that can be used by the elderly.This report examines the key therapeutic, product, market and regulatory factors for injection devices, READ MORE >

Executive Summary
Drug Injection Device Market Dynamics
Evolution in Injectable Drug Development
Injectable Drug Demand Drivers
Diseases and Indications
Syringe Economics
Chronic Conditions & Self-Administration
Technology Factors
Device Selection Factors
Market Segmentation
Product Features & Ease of Use
Competitive Landscape
Injection Device Suppliers
Capabilities and Market Presence
Technology and Infrastructure
Market Success Factors
Injection Devices
Autoinjectors
Dual Chamber Syringes
Needle-free Injectors
Pen Injectors
Prefilled Syringes
Safety Syringes
Emerging Device Classes
Wearable Injectors
Patch Pumps
Large Volume wearable Injectors
Risks and Opportunities
Injection Device Selection Criteria
Stability and Material Selection Issues
Single vs Multi-Dose Devices
Fixed vs Variable Dose Devices
Lyophilized Drugs/Reconstitution
Syringe Safety/Sharps Protection
Needle Configuration Strategies
Disposable Drug Cartridges
Human Engineering/Ergonomics
Branding/Private Labeling
Drug Delivery Devices – Device Classes and Analysis
Autoinjectors
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Autoinjector-specific Selection Factors
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Device Evolution and Market Impact
Dual Chamber Syringes
Needle-free Injectors
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source/Injection Site Selection
Injection Site Selection
Needle-free Injectors – the Next Six Years
Pen Injectors
Recent Segment Evolution and Product Consolidation
Pen Design and Device Selection
Standardized Pen Platforms
Custom Pen Designs
Pen Classes
Reusable Pens
Disposable Pens
Dual Chamber Pens
Pen Injector Evolution and Growth
Prefilled Syringes
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Plastic Prefilled Syringes
Prefillable Safety Syringes
Prefilled Syringe Selection Factors
Ready to Fill Prefillable Syringes
Fill-and-Finish CSO Selection
PFS Trending and Evolution – the Next Six Years
Safety Syringes
Safety Syringe Device Categories
Integrated Safety Syringes
Automatic Safety Mechanism
Manual Safety Mechanism
Post Manufacture Add-on/Bolt-on Safety Mechanisms
Safety Syringes – Market Evolution and Segment Expectations
Wearable Injectors
Patch Pumps
Large Volume Wearable Injectors
Drug Injection Device Market Segment Analysis & Forecasts
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Diabetes
Emergency Medicine
Hematopoietics
Hormone Replacement
Neurology
Osteoporosis
Reproductive Health
Vaccines
Injectable Drug Therapeutics - Market Factors
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Managed Care and Healthcare Economics
Company Profiles

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos